Binding properties of somatostatin receptor subtypes
References (15)
- et al.
Cloning, functional expression and pharmalogical characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype
Biochem Biophys Res Commun
(1993) - et al.
Somatostatin antagonist analog increases GH, insulin and glucagon release in the rat
Peptides
(1982) - et al.
Pertussis toxinsensitive airway beta-adrenergic dysfunction by somatostatin
Respir Physiol
(1994) - et al.
Molecular pharmacology of somatostatin receptors
Naunyn Schmiedeberg's Arch Pharmacol
(1994) - et al.
Molecular pharmacology of somatostatin receptor subtypes
Ann NY Acad Sci
(1994) - et al.
Molecular biology of somatostatin receptors
Endocr Rev
(1995) - et al.
Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28
Mol Pharmacol
(1992)
Cited by (115)
Morpho-functional analysis of the early changes induced in retinal ganglion cells by the onset of diabetic retinopathy: The effects of a neuroprotective strategy
2022, Pharmacological ResearchCitation Excerpt :Three days after STZ injection, 9 mice from the STZ-treated group were randomly assigned to the OCT treatment group and intravitreally injected with 1 µl of an OCT (Sigma-Aldrich) solution containing an amount of OCT to reach a final intravitreal OCT concentration of about 1 mM (considering a vitreous volume of 5 µl). According to previous studies, 1 mM OCT is a concentration giving maximal receptor occupancy in different systems [27–30], including the mouse retina [20,31,32]. Nine mice from the control group were also intravitreally injected with OCT.
Microscale radiosynthesis, preclinical imaging and dosimetry study of [<sup>18</sup>F]AMBF<inf>3</inf>-TATE: A potential PET tracer for clinical imaging of somatostatin receptors
2018, Nuclear Medicine and BiologyCitation Excerpt :In contrast, [18F]FDG imaging, a measure of tissue glucose metabolic activity, showed a reverse pattern with lower [18F]FDG metabolism in AR42J tumors than RM1 tumors (2.44 ± 0.57%ID/g and 5.25 ± 2.14%ID/g, respectively; p < 4.4e-2). Similarities in somatostatin peptide binding affinity between mouse and human SSTR2 suggest that mouse dosimetry provides a good estimation for human dosimetry [65,66]. Absorbed doses for [18F]AMBF3-TATE in humans were extrapolated from mouse PET biodistribution data using two extrapolation methods, Method 1 and Method 2 (see Supplementary Information, Section 4).
The role of brain somatostatin receptor 2 in the regulation of feeding and drinking behavior
2015, Hormones and BehaviorSomatostatin receptors: From signaling to clinical practice
2013, Frontiers in NeuroendocrinologyRobust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE
2012, Nuclear Medicine and BiologySomatostatin, Alzheimer's disease and cognition: An old story coming of age?
2009, Progress in Neurobiology